ES2104736T3 - Esteroides con puente de 2beta,19-metileno-amino utilizados como inhibidores de aromatasa. - Google Patents

Esteroides con puente de 2beta,19-metileno-amino utilizados como inhibidores de aromatasa.

Info

Publication number
ES2104736T3
ES2104736T3 ES91920606T ES91920606T ES2104736T3 ES 2104736 T3 ES2104736 T3 ES 2104736T3 ES 91920606 T ES91920606 T ES 91920606T ES 91920606 T ES91920606 T ES 91920606T ES 2104736 T3 ES2104736 T3 ES 2104736T3
Authority
ES
Spain
Prior art keywords
aromatase inhibitors
2beta
methylene
amino used
steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91920606T
Other languages
English (en)
Spanish (es)
Inventor
J O'neal Johnston
Norton P Peet
Joseph P Burkhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2104736T3 publication Critical patent/ES2104736T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES91920606T 1990-11-30 1991-10-17 Esteroides con puente de 2beta,19-metileno-amino utilizados como inhibidores de aromatasa. Expired - Lifetime ES2104736T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/621,183 US5126488A (en) 1990-11-30 1990-11-30 2β,19-methyleneamino bridged steroids as aromatase inhibitors

Publications (1)

Publication Number Publication Date
ES2104736T3 true ES2104736T3 (es) 1997-10-16

Family

ID=24489088

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91920606T Expired - Lifetime ES2104736T3 (es) 1990-11-30 1991-10-17 Esteroides con puente de 2beta,19-metileno-amino utilizados como inhibidores de aromatasa.

Country Status (15)

Country Link
US (1) US5126488A (esLanguage)
EP (1) EP0559706B1 (esLanguage)
JP (1) JP3021651B2 (esLanguage)
KR (1) KR100200462B1 (esLanguage)
AT (1) ATE154606T1 (esLanguage)
AU (1) AU647226B2 (esLanguage)
CA (1) CA2096020C (esLanguage)
DE (1) DE69126622T2 (esLanguage)
DK (1) DK0559706T3 (esLanguage)
ES (1) ES2104736T3 (esLanguage)
FI (1) FI932446A7 (esLanguage)
GR (1) GR3024298T3 (esLanguage)
HU (1) HU213608B (esLanguage)
NO (1) NO302123B1 (esLanguage)
WO (1) WO1992009619A1 (esLanguage)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510340A (en) * 1992-06-12 1996-04-23 Sri International Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
JP2008539047A (ja) 2005-04-28 2008-11-13 プロテウス バイオメディカル インコーポレイテッド ファーマインフォーマティックスシステム
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
NZ236473A (en) * 1989-12-20 1993-04-28 Merrell Dow Pharma 2,19-methyleneoxy and 2,19-methylenethio bridged steroids and pharmaceutical compositions

Also Published As

Publication number Publication date
DE69126622D1 (de) 1997-07-24
EP0559706A1 (en) 1993-09-15
WO1992009619A1 (en) 1992-06-11
GR3024298T3 (en) 1997-10-31
HU213608B (en) 1997-08-28
KR100200462B1 (ko) 1999-06-15
US5126488A (en) 1992-06-30
AU9027991A (en) 1992-06-25
JPH06509543A (ja) 1994-10-27
ATE154606T1 (de) 1997-07-15
NO931951D0 (no) 1993-05-28
FI932446L (fi) 1993-05-28
EP0559706B1 (en) 1997-06-18
FI932446A0 (fi) 1993-05-28
JP3021651B2 (ja) 2000-03-15
CA2096020A1 (en) 1992-05-31
DK0559706T3 (da) 1997-09-08
DE69126622T2 (de) 1997-10-23
CA2096020C (en) 2003-06-17
NO302123B1 (no) 1998-01-26
EP0559706A4 (esLanguage) 1994-02-09
AU647226B2 (en) 1994-03-17
NO931951L (no) 1993-05-28
HUT64365A (en) 1993-12-28
FI932446A7 (fi) 1993-05-28

Similar Documents

Publication Publication Date Title
DE69116550D1 (de) Steroid-sulfatase-inhibitoren
ES2155874T3 (es) Composiciones cosmeticas que contienen acido betulinico.
SV1996000114A (es) Nuevos plaguicidas
DE3686525D1 (de) Hochfeste einkristall-superlegierungszusammensetzungen.
NO965516L (no) Sterolderivater anvendt til regulering av meiose
CA2003391A1 (en) Silicone hairspray compositions
DK0868188T3 (da) Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen
DK623684A (da) Flertrinskombinationspraeparat og dets anvendelse til oral kontraception
PT775156E (pt) Preparacoes farmaceuticas contendo derivados de estra-1,3,5(10)-trieno
ES2132791T3 (es) Proceso de preparacion de una composicion de caucho y cubierta de neumatico producida con la misma.
HUP9900301A2 (hu) Hormontapasz
YU58599A (sh) Gelovi sa usporenim podržanim oslobađanjem
CO4230020A1 (es) Derivados glicosidos esteroidales y composiciones farmaceuti cas que los contienen .
ES2104736T3 (es) Esteroides con puente de 2beta,19-metileno-amino utilizados como inhibidores de aromatasa.
FI915404A7 (fi) Endometrisiä ponneaineita, koostumuksia ja sovellutuksia
ES2168464T3 (es) Composicion acondicionadora del cabello.
ES2042556T3 (es) N,n'-diacilhidrazinas n-sustituidas, n'-sustituidas insecticidas.
CO4230021A1 (es) Glicosidos esteroideos, procedimientos de uso de los mismos como agentes hipocolesterolemicos y agentes antiateroscle- roticos en mamiferos.
FR2599759B1 (fr) Alliages monocristallins renforces par dispersion
ES2063796T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden- y 2'-etinil-adenosina.
NZ188755A (en) Formulations of steroids of estrane,androstane and 19-nor-pregnane series and tocol or a derivative thereof
GB1240719A (en) New 11-halogenosteroids
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
FI956028A7 (fi) Estreenisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neuroke miallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostum ukset ja menetelmät
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 559706

Country of ref document: ES